Candel Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $1,776 | $1,776 |
Gross Profit | -249 | -251 | 1,464 |
EBITDA | -21,421 | -7,324 | -10,006 |
EBIT | -21,670 | -7,575 | -10,318 |
Net Income | -22,237 | -8,221 | -11,095 |
Net Change In Cash | 0 | 1,776 | 1,776 |
Free Cash Flow | -6,204 | -8,445 | -7,469 |
Cash | 21,454 | 25,713 | 35,413 |
Basic Shares | 29,878 | 29,197 | 28,981 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $31 | $125 | $125 | $125 |
Gross Profit | -23,980 | -862 | 125 | 125 |
EBITDA | -37,431 | -17,317 | -35,839 | -13,719 |
EBIT | -38,391 | -18,304 | -36,071 | -13,810 |
Net Income | -37,939 | -2,866 | -36,124 | -22,174 |
Net Change In Cash | 31 | 125 | 125 | 125 |
Cost of Revenue | 47,747 | |||
Free Cash Flow | -34,701 | -32,716 | -24,053 | -10,547 |
Cash | 35,413 | 70,058 | 82,642 | 35,053 |
Basic Shares | 28,935 | 28,823 | 28,689 | 29,148 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.33 |
2024-06-30 | -$0.74 |
2024-03-31 | -$0.28 |
2023-12-31 | -$0.38 |
